Background and purpose: To evaluate the prevalence and the prognostic implications of conduction delays in a large cohort of cardiac AL patients. Methods: Echo Doppler and 12-lead ECG were collected in 344 consecutive patients in whom diagnosis of AL amyloidosis was concluded between 2008 and 2010. Patients were subdivided according to the presence (n= 240) or absence (n= 104) of cardiac involvement. Results: When compared with patients without myocardial involvement, cardiac AL was associated with prolonged PQ, QRS, QT and QTc intervals (P< 0.05), and with higher prevalence of intraventricular blocks (27.5% vs. 16.5%, P< 0.05), that was associated with higher wall thickness, worse diastolic and regional systolic function, higher NT...
AIM: Amyloidosis is a systemic disease, related to different underlying causes, with frequent cardia...
Aims Patients with AA and AL amyloidosis have a limited life-expectancy. The aim of this study was t...
Aims AL amyloidosis may respond to chemotherapy but two-thirds of patients with severe cardiac invol...
Background and purpose: To evaluate the prevalence and the prognostic implications of conduction del...
Prognostic value of cardiac conduction delays in light-chain (AL) amyloidosis Among the different...
BACKGROUND Arrhythmias in cardiac amyloidosis (CA) result in significant comorbidity and mortalit...
Background: In light-chain (AL) cardiac amyloidosis, the 12-lead electrocardiogram (ECG) reflects my...
© 2016 European Society of Cardiology. All rights reserved.Background: Rhythm disturbances and condu...
Cardiac amyloidosis is an infiltrative disease of the myocardium. Nearly all cases of clinical cardi...
Background In cardiac AL amyloidosis, myocardial infiltration is typically associated with low QRS v...
BACKGROUND: Patients with AL amyloidosis often present with signs of congestive heart failure. AIM: ...
Cardiac involvement in amyloidosis is associated with a poor prognosis. Data on the burden of arrhyt...
AbstractObjectives. This study sought to determine the spectrum of electrophysiologic abnormalities ...
The heart is involved in more than one third of patients with primary (AL) amyloidosis at diagnosis ...
Background: Clinical recognition of cardiac involvement and cardiac response to therapy is an import...
AIM: Amyloidosis is a systemic disease, related to different underlying causes, with frequent cardia...
Aims Patients with AA and AL amyloidosis have a limited life-expectancy. The aim of this study was t...
Aims AL amyloidosis may respond to chemotherapy but two-thirds of patients with severe cardiac invol...
Background and purpose: To evaluate the prevalence and the prognostic implications of conduction del...
Prognostic value of cardiac conduction delays in light-chain (AL) amyloidosis Among the different...
BACKGROUND Arrhythmias in cardiac amyloidosis (CA) result in significant comorbidity and mortalit...
Background: In light-chain (AL) cardiac amyloidosis, the 12-lead electrocardiogram (ECG) reflects my...
© 2016 European Society of Cardiology. All rights reserved.Background: Rhythm disturbances and condu...
Cardiac amyloidosis is an infiltrative disease of the myocardium. Nearly all cases of clinical cardi...
Background In cardiac AL amyloidosis, myocardial infiltration is typically associated with low QRS v...
BACKGROUND: Patients with AL amyloidosis often present with signs of congestive heart failure. AIM: ...
Cardiac involvement in amyloidosis is associated with a poor prognosis. Data on the burden of arrhyt...
AbstractObjectives. This study sought to determine the spectrum of electrophysiologic abnormalities ...
The heart is involved in more than one third of patients with primary (AL) amyloidosis at diagnosis ...
Background: Clinical recognition of cardiac involvement and cardiac response to therapy is an import...
AIM: Amyloidosis is a systemic disease, related to different underlying causes, with frequent cardia...
Aims Patients with AA and AL amyloidosis have a limited life-expectancy. The aim of this study was t...
Aims AL amyloidosis may respond to chemotherapy but two-thirds of patients with severe cardiac invol...